Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Mangoceuticals, Inc. MGRX

Set alert

Price alert · MGRX

All alert types
0.24 USD +0.01 +3.68%

As of Nov 2, 9:59 AM ET

Bid
0.23 × 2
Ask
0.26 × 2
0.2337 Day range 0.2424
0.162 52-week range 2.41
YTD
-67.30%
1 year
-88.37%
Open
0.2375
Prev close
0.2334
Mkt cap
5.38M
Vol
10.08K
Avg vol
3.54M
EPS
-1.02
P/E
0.00
Div yield
0.00%
More statistics
Low
0.2337
High
0.2424
Forward P/E
0.00
Beta
0.00
Short ratio
0.21
Inst. own
4.69%
Dividend
0.00
Ex-div date
50-d avg
2.49
200-d avg
3.94
1y target
0.00

MAX chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The all-time price history for MGRX has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-6.10 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C+2 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 5

Valuation

P/E -0.3×
FY 2021: -3922×FY 2022: -34.7×FY 2023: -0.6×FY 2024: -0.5×FY 2025: -0.3×
FY 2021 5y median -0.6× FY 2025
P/S 16.3×
FY 2021: 0.0×FY 2022: 7748×FY 2023: 8.1×FY 2024: 7.8×FY 2025: 16.3×
FY 2021 5y median 8.1× FY 2025
P/B 0.5×
FY 2021: -4142×FY 2022: 113×FY 2023: 7.6×FY 2024: 0.3×FY 2025: 0.5×
FY 2021 5y median 0.5× FY 2025
P/FCF -1.3×
FY 2021: -3953×FY 2022: -49.8×FY 2023: -0.8×FY 2024: -1.0×FY 2025: -1.3×
FY 2021 5y median -1.3× FY 2025
EV/EBITDA -0.3×
FY 2021: -3954×FY 2022: -34.7×FY 2023: -0.7×FY 2024: -0.6×FY 2025: -0.3×
FY 2021 5y median -0.7× FY 2025
EV/Sales 13.8×
FY 2021: 0.0×FY 2022: 7711×FY 2023: 7.3×FY 2024: 8.0×FY 2025: 13.8×
FY 2021 5y median 8.0× FY 2025
FCF Yield -78.5%
FY 2021: -0.0%FY 2022: -2.0%FY 2023: -118.1%FY 2024: -101.6%FY 2025: -78.5%
FY 2021 5y median -78.5% FY 2025

Profitability

Gross Margin 54.9%
FY 2021: 0.0%FY 2022: 54.3%FY 2023: 59.0%FY 2024: 61.7%FY 2025: 54.9%
FY 2021 5y median 54.9% FY 2025
Operating Margin -4200.5%
FY 2021: 0.0%FY 2022: -22279.7%FY 2023: -1260.3%FY 2024: -1294.4%FY 2025: -4200.5%
FY 2021 5y median -1294.4% FY 2025
Net Margin -4526.9%
FY 2021: 0.0%FY 2022: -22352.1%FY 2023: -1259.4%FY 2024: -1413.6%FY 2025: -4526.9%
FY 2021 5y median -1413.6% FY 2025
ROE -135.8%
FY 2021: 105.9%FY 2022: -325.4%FY 2023: -1189.1%FY 2024: -62.4%FY 2025: -135.8%
FY 2021 5y median -135.8% FY 2025
ROIC -123.5%
FY 2021: -77.7%FY 2022: -206.0%FY 2023: -1020.4%FY 2024: -56.3%FY 2025: -123.5%
FY 2021 5y median -123.5% FY 2025
ROA -128.3%
FY 2021: -78.5%FY 2022: -199.2%FY 2023: -876.7%FY 2024: -56.6%FY 2025: -128.3%
FY 2021 5y median -128.3% FY 2025

Growth (YoY)

Revenue -26.0%
FY 2021: 0.0%FY 2022: 0.0%FY 2023: 8083.2%FY 2024: -15.8%FY 2025: -26.0%
FY 2021 FY 2025
Operating Income -140.3%
FY 2021: 0.0%FY 2022: -11267.5%FY 2023: -362.9%FY 2024: 13.5%FY 2025: -140.3%
FY 2021 FY 2025
EPS (diluted) 50.7%
FY 2021: 0.0%FY 2022: -11207.2%FY 2023: -272.8%FY 2024: 31.8%FY 2025: 50.7%
FY 2021 FY 2025
Free Cash Flow -20.3%
FY 2021: 0.0%FY 2022: -7831.6%FY 2023: -403.8%FY 2024: 30.5%FY 2025: -20.3%
FY 2021 FY 2025

Financial Health

Current Ratio 1.7×
FY 2021: 0.6×FY 2022: 2.7×FY 2023: 3.9×FY 2024: 0.1×FY 2025: 1.7×
FY 2021 5y median 1.7× FY 2025
Quick Ratio 1.7×
FY 2021: 0.6×FY 2022: 2.7×FY 2023: 3.8×FY 2024: 0.1×FY 2025: 1.7×
FY 2021 5y median 1.7× FY 2025
Debt / Equity 0.0×
FY 2021: -2.3×FY 2022: 0.6×FY 2023: 0.2×FY 2024: 0.0×FY 2025: 0.0×
FY 2021 5y median 0.0× FY 2025
Net Debt / EBITDA 0.1×
FY 2021: -1.0×FY 2022: 0.2×FY 2023: 0.1×FY 2024: -0.0×FY 2025: 0.1×
FY 2021 5y median 0.1× FY 2025
Interest Coverage -185×
FY 2021: -96.8×FY 2022: -308×FY 2023: 0.0×FY 2024: -582×FY 2025: -185×
FY 2021 5y median -185× FY 2025

Dividends

Dividend Yield 0.0%
FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 16.7%FY 2025: 0.0%
FY 2021 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: -9.2%FY 2025: 0.0%
FY 2021 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31